NCT02810795

Brief Summary

The purpose of this study is to determine the diagnostic accuracy of MPICT for the detection of hemodynamically relevant coronary stenosis (as determined by invasive FFR) in patients with suspected or known CAD clinically referred for invasive angiography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2016

Completed
Same day until next milestone

Study Start

First participant enrolled

June 7, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 23, 2016

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2020

Completed
Last Updated

December 11, 2020

Status Verified

December 1, 2020

Enrollment Period

4.5 years

First QC Date

June 7, 2016

Last Update Submit

December 10, 2020

Conditions

Keywords

CoronaryArteryComputed tomographyFFRCT myocardial perfusionDynamic

Outcome Measures

Primary Outcomes (1)

  • Myocardial perfusion

    invasive fractional flow reserve measurement

    For each patient within 4 weeks of the CT perfusion acquisition

Secondary Outcomes (8)

  • Presence of myocardial perfusion defect on MPIMRI

    For each patient within 1 week before invasive fractional flow reserve measurement

  • Per patient assessment of hemodynamically significant CAD

    For each patient within 4 weeks of the CT perfusion acquisition

  • Ischemia per standardized myocardial segment

    For each patient within 4 weeks of the CT perfusion acquisition

  • Coronary stenosis by CTA per territory (branch)

    For each patient within 4 weeks of the CT perfusion acquisition

  • Coronary stenosis by invasive angiography per territory (branch)

    For each patient within 4 weeks of the CT perfusion acquisition

  • +3 more secondary outcomes

Interventions

Myocardial perfusion defect on dynamic CT perfusion imaging, and diagnostic accuracy as compared invasive FFR.

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with know or suspect coronary artery diseased, referred for invasive coronary angiography.

You may qualify if:

  • Age 21-75 years
  • Stable angina symptoms, suspected or known CAD, and referred for invasive angiography on clinical grounds.
  • Ability to provide informed consent
  • Ability to perform a 20-30 second breath hold

You may not qualify if:

  • Hemodynamically and clinically unstable condition (angina at rest, malignant arrhythmias)
  • Prior, documented myocardial infarction, other than (procedure related) minor type II myocardial infarction, which includes Q waves on the ECG or evidence of myocardial infarction on prior non-invasive imaging.
  • Prior stenting or coronary artery bypass graft surgery
  • Significant other cardiovascular conditions affecting the interpretation of MPICT, including, but not limited to: clinical heart failure, IECD (pacemaker/ICD), severe valvular heart disease or prosthetic valves, significant intra-cardiac shunting or other relevant congenital heart disease.
  • eGFR\<60 ml/kg/min
  • BMI\>30 kg/m2, or weight \>120 kg.
  • Atrial fibrillation or other arrhythmia, \>6 ectopic beats / min
  • Known or suspected allergy to iodinated contrast medium
  • Pregnancy cannot be excluded
  • Contra-indications for adenosine: bronchial asthma, second or third degree atrioventricular block, blood pressure \<110/70 mmHg, allergies or severe side effects in the past.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ErasmusMC

Rotterdam, South Holland, 3015CE, Netherlands

Location

Related Publications (2)

  • Soschynski M, Storelli R, Birkemeyer C, Hagar MT, Faby S, Schwemmer C, Nous FMA, Pugliese F, Vliegenthart R, Schlett CL, Nikolaou K, Krumm P, Nieman K, Bamberg F, Artzner CP. CT Myocardial Perfusion and CT-FFR versus Invasive FFR for Hemodynamic Relevance of Coronary Artery Disease. Radiology. 2024 Aug;312(2):e233234. doi: 10.1148/radiol.233234.

  • Nous FMA, Geisler T, Kruk MBP, Alkadhi H, Kitagawa K, Vliegenthart R, Hell MM, Hausleiter J, Nguyen PK, Budde RPJ, Nikolaou K, Kepka C, Manka R, Sakuma H, Malik SB, Coenen A, Zijlstra F, Klotz E, van der Harst P, Artzner C, Dedic A, Pugliese F, Bamberg F, Nieman K. Dynamic Myocardial Perfusion CT for the Detection of Hemodynamically Significant Coronary Artery Disease. JACC Cardiovasc Imaging. 2022 Jan;15(1):75-87. doi: 10.1016/j.jcmg.2021.07.021. Epub 2021 Sep 15.

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Koen Nieman, MD PHD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. K. Nieman MD, PHD

Study Record Dates

First Submitted

June 7, 2016

First Posted

June 23, 2016

Study Start

June 7, 2016

Primary Completion

December 10, 2020

Study Completion

December 10, 2020

Last Updated

December 11, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations